According to additional research, MPN was categorized into groups by Wang et al. The levels of PD-1 and PD-L1 in CD4+CD8+CD14+CD34+ progenitor cells when PV, ET, and MF were separated into MPN were significantly different from those of the control group. The gene discussed is CD34; the disease is myeloproliferative neoplasm.